Leerink Partners Initiates Coverage On NeuroPace with Outperform Rating, Announces Price Target of $22

NEUROPACE, INC. -4.56%

NEUROPACE, INC.

NPCE

8.17

-4.56%

Leerink Partners analyst Mike Kratky initiates coverage on NeuroPace (NASDAQ: NPCE) with a Outperform rating and announces Price Target of $22.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via